Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw

Gent, Belgium

Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw

Gent, Belgium

Time filter

Source Type

Patent
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw and Life Sciences Partners | Date: 2010-02-10

The present invention relates to the treatment of motoneuron diseases. More particularly, the invention relates to the treatment of amyotrophic lateral sclerosis (ALS). It is found that the intracerebroventricular delivery of low amounts of vascular endothelial growth factor into a pre-clinical ALS animal model induces a significant motor performance and prolongation of survival time of the animals.


Patent
ThromboGenics, Life Sciences Partners and Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Date: 2012-05-02

The present invention provides novel monoclonal antibodies directed to PIGF and fragments and derivatives thereof, more particularly to humanized antibodies and fragments thereof for use in the treatment and/or prevention of pathological angiogenesis.


Patent
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Date: 2012-03-07

A chimeric, carboxy-terminal truncated hepatitis B virus nucleocapsid (HBc) protein is disclosed that contains an immunogen for inducing the production of antibodies to the influenza M2 protein. An immunogenic influenza sequence in two to four copies is preferably expressed at or near the N-terminus or in the HBc immunogenic loop sequence. The HBc chimer preferably contains an influenzaspecific T cell epitope and is preferably engineered for both enhanced stability of self-assembled particles and enhanced yield of those chimeric particles. Methods of making and using the chimers are also disclosed.


A method for the preparation of a eukaryotic organism, for example selected from plants, animals and fungi, showing constitutive, inducible and/or organ specific expression of a specifically modified TPS gene, which comprises the steps of providing a TPS gene; designing a suitable modification to the TPS gene by aligning the gene with the corresponding gene of yeast and establishing which part of the gene extends beyond the 5 terminus of the yeast gene; deleting or inactivating a part of the N-terminal region of the TPS gene extending beyond the 5 terminus of the yeast gene, in order to achieve an increased trehalose-6-phosphate synthase activity; cloning the thus modified gene into an expression vector under the control of a constitutive, inducible and/or organ-specific promoter; transforming a plant cell or tissue with the thus obtained expression vector; and regenerating a complete plant from the transformed plant cell or tissue.

Loading Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw collaborators
Loading Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw collaborators